Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Prato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
ItalyStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
ItalyStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
ItalyStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
ItalyEvaluating Datopotamab Deruxtecan with drug combination in adults with TROP2‑positive non‑small cell lung cancer
ItalyA Phase III Study of Once‑Weekly Petrelintide to Evaluate Efficacy and Safety for Weight Loss in Adults with Overweight or Obesity
ItalyStudy of galvokimig versus placebo to assess safety and effectiveness in adults with moderate‑to‑severe chronic obstructive pulmonary disease with chronic bronchitis
ItalyEfficacy and safety of GIA632 versus placebo in adults with moderate to severe cutaneous lichen planus
ItalyPhase 2b Randomized Double‑Blind Study of ALN‑CIDEB in Adults with Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalyPhase 2 Study of Oral VS-7375 in Adults with Advanced KRAS G12D‑Mutated Non‑Small Cell Lung Cancer Previously Treated
ItalyGedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer
ItalyA Phase 3 Study of ASP2138 Plus Drug Combination in Adults with HER2‑Negative, CLDN18.2‑Positive Advanced Gastric Cancer (First‑Line Treatment)
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including innovative therapies and maintenance strategies.
Multiple studies evaluating novel drug combinations and personalized treatment approaches for various breast cancer subtypes.
Innovative research in colorectal cancer and pancreatic cancer, exploring new treatment combinations and maintenance therapies.
Studies focus on improving survival rates and treatment effectiveness for advanced gastrointestinal cancers.
Research targeting ovarian cancer and related conditions, with emphasis on platinum-sensitive diseases and novel therapeutic combinations.
Trials exploring new approaches for treating various types of gynecologic cancers with innovative drug combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
